- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Vitamin D may help prevent COVID-19 induced preeclampsia or hypertension: Study
Vitamin D is effective in preventing COVID-19 induced preeclampsia or hypertension, according to the latest study published in the Medical Hypotheses.
A group of researchers conducted a study to examine the role of Vitamin D in covid-19 induced pregnancy complications.
The pregnancy is considered a physiological condition, that is accompanied by hypervolemia, increased cardiac output, and a diminished total peripheral resistance, still, the pregnants are normotensive, and blood pressure even tends to decrease in the second trimester. Estrogen and progesterone raise angiotensinogen and renin levels, which in turn leads to increased angiotensin II levels, the increased concentration of angiotensinogen, angiotensin II, indicate the increased activity of RAAS, but instead, there is a decrease in systemic vascular resistance characterizes the hemodynamics of the normal pregnancy
SARS-CoV-2 enters target cells via the ACE2 receptor and downregulates them. ACE2 exhibits high catalytic activity to produce Angiotensin 1–7 (Ang-1–7), which has a vasodilator effect and also inactivates the vasoconstrictor Angiotensin II. In normal pregnancy, ACE2 expression is raised in the uterus and placenta. Ang-1–7 levels in plasma are significantly higher in third-trimester pregnant women when compared to non-pregnant women.
This may be contributing to systemic vasodilation and reduced blood pressure and modulating hemodynamics during pregnancy. Interestingly, Ang-1–7 plasma levels are lower in pregnancies complicated by pre-eclampsia than in normal pregnancies. COVID-19 infection increased the inflammatory cytokines and reduced ACE2 levels.
This may lead to pre-eclampsia or hypertensive pregnancies, then increasing the perinatal and maternal mortality and morbidity. Vitamin D increased ACE2 expression and Ang-1–7 plasma levels and also decreased Ang II levels in plasma.
Moreover, Vitamin D reduced the inflammatory cytokine storm. So, the researchers concluded that Vitamin D supplementation can prevent the risk of preeclampsia or hypertension in pregnant women with COVID-19.
Reference:
Vitamin D may prevent COVID-19 induced pregnancy complications by AliAl-Kaleel et al. published in the Medical Hypotheses.
https://doi.org/10.1016/j.mehy.2021.110733
Dr. Shravani Dali has completed her BDS from Pravara institute of medical sciences, loni. Following which she extensively worked in the healthcare sector for 2+ years. She has been actively involved in writing blogs in field of health and wellness. Currently she is pursuing her Masters of public health-health administration from Tata institute of social sciences. She can be contacted at editorial@medicaldialogues.in.
Dr Kamal Kant Kohli-MBBS, DTCD- a chest specialist with more than 30 years of practice and a flair for writing clinical articles, Dr Kamal Kant Kohli joined Medical Dialogues as a Chief Editor of Medical News. Besides writing articles, as an editor, he proofreads and verifies all the medical content published on Medical Dialogues including those coming from journals, studies,medical conferences,guidelines etc. Email: drkohli@medicaldialogues.in. Contact no. 011-43720751